Presentation is loading. Please wait.

Presentation is loading. Please wait.

Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor  Meredith C. Fidler, Jack Beusmans, Paul Panorchan,

Published byἩλί Μπλέτσας Modified over 6 years ago

Similar presentations

Presentation on theme: "Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor  Meredith C. Fidler, Jack Beusmans, Paul Panorchan,"— Presentation transcript:

1 Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor  Meredith C. Fidler, Jack Beusmans, Paul Panorchan, Fredrick Van Goor  Journal of Cystic Fibrosis  Volume 16, Issue 1, Pages (January 2017) DOI: /j.jcf Copyright © 2016 The Authors Terms and Conditions

2 Fig. 1 Correlation between absolute change from baseline of ppFEV1 and sweat chloride level (mmol/L) in patients with CF treated with ivacaftor. Journal of Cystic Fibrosis  , 41-44DOI: ( /j.jcf ) Copyright © 2016 The Authors Terms and Conditions

3 Fig. 2 Correlation between individual absolute change from baseline of ppFEV1 and sweat chloride level (mmol/L) in patients with CF treated with ivacaftor. Journal of Cystic Fibrosis  , 41-44DOI: ( /j.jcf ) Copyright © 2016 The Authors Terms and Conditions

Download ppt "Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor  Meredith C. Fidler, Jack Beusmans, Paul Panorchan,"

Similar presentations

Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.

Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.
Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis  Michael W. Konstan, Felix Ratjen 

Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis  Michael W. Konstan, Felix Ratjen 
Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutation  Helge Hebestreit, Annette Sauer-Heilborn, Rainald Fischer,

Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutation  Helge Hebestreit, Annette Sauer-Heilborn, Rainald Fischer,
Dorene F. Balmer, Joan I. Schall, Virginia A. Stallings 

Dorene F. Balmer, Joan I. Schall, Virginia A. Stallings 
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,
Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function  Fredrick Van Goor, Haihui Yu, Bill.

Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function  Fredrick Van Goor, Haihui Yu, Bill.
Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients  Karen.

Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients  Karen.
Use of high-dose ibuprofen in a pediatric cystic fibrosis center

Use of high-dose ibuprofen in a pediatric cystic fibrosis center
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 

How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
H. Grasemann, E. Tullis, F. Ratjen  Journal of Cystic Fibrosis 

H. Grasemann, E. Tullis, F. Ratjen  Journal of Cystic Fibrosis 
Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation  Gemma L. Zeybel, Jeffrey P. Pearson, Amaran Krishnan,

Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation  Gemma L. Zeybel, Jeffrey P. Pearson, Amaran Krishnan,
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 

Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.

Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Nadav Traeger, Qiuhu Shi, Allen J. Dozor  Journal of Cystic Fibrosis 

Nadav Traeger, Qiuhu Shi, Allen J. Dozor  Journal of Cystic Fibrosis 
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 

Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis  C.J. Taylor, R. Thieroff-Ekerdt, S. Shiff, L.

Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis  C.J. Taylor, R. Thieroff-Ekerdt, S. Shiff, L.
Frank J. Accurso, Fredrick Van Goor, Jiuhong Zha, Anne J

Frank J. Accurso, Fredrick Van Goor, Jiuhong Zha, Anne J
Cirrhosis and other liver disease in cystic fibrosis

Cirrhosis and other liver disease in cystic fibrosis
John Widger, Sarath Ranganathan, Philip J. Robinson 

John Widger, Sarath Ranganathan, Philip J. Robinson 

Similar presentations

Ads by Google